Case study of the anemic patient: epoetin alfa--focus on erythrokinetics.
Erythrokinetics is a physiologic process that regulates red blood cell dynamics. In keeping with the present trend of focusing on patient outcomes and costs, an erythrokinetic model provides a guideline for appropriate dosing of Epoetin alfa to maintain a hematocrit within the target range of 30% to 36%. Maintaining the patient's hematocrit at the optimal level influences patient outcomes by enhancing the quality of life and improving patient management by decreasing time and costs.